Wockhardt Limited (WOCKPHARMA)
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, the Proceedings of the 27th AGM of the Company
Proceedings of the 27th AGM held on 10-Aug-2026 via video conferencing
- All resolutions including adoption of FY26 financials and director reappointment passed
- Approval granted for remuneration revisions and material related party transactions
- Special resolution approved for raising up to ₹3,000 Cr capital via QIP
- Appointment of Ms. Zahabiya Khorakiwala as Executive Co-chairperson of subsidiary approved
- Voting conducted through remote e-voting and during AGM; results declared
- Total 187 members attended the AGM
- Chairman Dr. Habil Khorakiwala chaired and addressed the meeting
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 WOCKPHARMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add WOCKPHARMA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Wockhardt Limited
Important.
The summary above is generated automatically from Wockhardt Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.